Journal article

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus, Anna de Fazio, Gillian Mitchell, Sian Fereday, Kelly L Bolton, Charlie Gourley, Caroline Michie, Beth Karlan, Jenny Lester, Christine Walsh, Ilana Cass Show all

CLINICAL CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2015

Grants

Awarded by American Cancer Society Early Detection Professorship


Awarded by Cancer Australia


Awarded by Cancer Research UK


Awarded by Catalan Health Institute and Autonomous Government of Catalonia


Awarded by European Research Council


Awarded by National Cancer Institute


Awarded by National Health and Medical Research Council of Australia


Awarded by Ovarian Cancer Research Program of the US Department of Defense


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by Chief Scientist Office


Awarded by National Breast Cancer Foundation


Awarded by The Francis Crick Institute


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

F.J. Candido-dos-Reis was funded by the Sao Paulo Research Foundation (FAPESP). The contributing studies were funded by grants from The American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN); Asociacion Espanola Contra el Cancer; Cancer Australia (509303); the Cancer Council Victoria; the Cancer Council Queensland, the Cancer Council New South Wales; Cancer Research UK (C490/A10119, C490/A10124, C490/A16561); Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. (ISCIIIRETIC RD06/0020/105, PI10/01422, PI10/31488, 2009SGR290); the European Research Council (310018, 2011294576); the Mermaid Project (Mermaid 1); Ministero della Salute of Italy "5 x 1000" fund; the National Breast Cancer Foundation of Australia; National Cancer Institute (UM1CA164920, R01CA178535, R01CA61107, U01CA71966, R01CA16056, K07CA143047, and U01CA69417, P50CA136393, R01CA122443); the NIHR Biomedical Research Centres at the University of Cambridge and the Royal Marsden NHS Foundation Trust and Institute of Cancer Research; the National Health and Medical Research Council of Australia (400281, 400413); Ovarian Cancer Research Program of the US Department of Defense (W81XWH-08-1-0684 and W81XWH-08-10685); the Peter MacCallum Cancer Centre Foundation; Scottish Funding Council; the Seventh Framework Programme of the European Union (FP/2007-2013); Swedish Cancer Society; Spanish Health Research Fund; Swedish Research Council; the University of Sydney Cancer Research Fund; and U.S. Army Medical Research and Materiel Command (DAMD17-01-1-0729).